Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia

Recruiting N/A Interventional Study
Dyspareunia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
34 (estimated)
Sponsor
Institut Investigacio Sanitaria Pere Virgili · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The objective of this community-based, non-randomized, quasi-experimental study is to assess the effectiveness of BTL EXILIS technology-based on combined radiofrequency and ultrasound-in women of childbearing age from an industrialized country with a diagnosis of dyspareunia following vaginal delivery. The primary research question is: \- Do patients experience a resolution of pain during sexual…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women of childbearing age * Medical history of at least one prior vaginal delivery * Reported persistent pain during penetrative sexual intercourse * Meeting the clinical criteria for dyspareunia * Moderate to severe pain level, defined as a score of 4 or higher on the Visual …
Contacts

LYS GARCIA VILAPLANA, Lead Researcher

+34619357158

lys@procrear.es

CONTACT

CRISTINA REY REÑONES, DOCTORA

+34686853715

cristina.rey@urv.cat

CONTACT